| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.4 | 7e-19 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.054 | 0.3 |